Reto Wittwer has more than 25 years of professional experience as a CFO and as a tax adviser in the pharmaceutical industry. He serves as the Chief Financial Officer at DiNAQOR.
Mr. Wittwer has advised biotechnology and specialty pharmaceutical companies in strategic financial and transaction matters including Sandoz North America (Vice President & CFO) and Novartis (Vice President and Global CFO, Novartis Institutes of Biomedical Research; Global Head of Taxes). He has also been a Co-founder, board member and CFO of multiple biotech ventures.
A Certified Tax Expert, Mr. Wittwer obtained a Master of Law from the University of Zurich and Executive M.B.L.-HSG from the University of St. Gallen.